Helen of Troy Limited

Helen of Troy Limited (HELE) Market Cap

Helen of Troy Limited has a market capitalization of $435.1M.

Financials based on reported quarter end 2025-11-30

Price: $18.86

β–² 1.07 (6.01%)

Market Cap: 435.14M

NASDAQ Β· time unavailable

CEO: George Scott Uzzell

Sector: Consumer Defensive

Industry: Household & Personal Products

IPO Date: 1976-07-08

Website: https://www.helenoftroy.com

Helen of Troy Limited (HELE) - Company Information

Market Cap: 435.14M Β· Sector: Consumer Defensive

Helen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates through three segments: Home & Outdoor, Health & Wellness, and Beauty. The Home & Outdoor segment offers food preparation tools and gadgets, storage containers, and organization products; coffee makers, grinders, manual pour overs, and tea kettles; household cleaning products, shower organization, and bathroom accessories; feeding and drinking products, child seating products, cleaning tools, and nursery accessories; insulated water bottles, hydration packs, drinkware, mugs, food containers, lunch containers, insulated totes, soft coolers, and accessories; and technical and outdoor sports packs, travel packs, luggage, daypacks, and everyday packs. The Health & Wellness segment provides thermometers, blood pressure monitors, pulse oximeters, nasal aspirators, and humidifiers; faucet mount water-filtration systems and pitcher-based water filtration systems; and air purifiers, heaters, fans, and humidifiers. The Beauty segment offers grooming brushes, tools, and decorative hair accessories; and shampoos, liquid hair styling, and treatment and conditioning products, as well as hair appliances. The company sells its products through mass merchandisers, drugstore chains, warehouse clubs, home improvement stores, grocery and specialty stores, beauty supply and e-commerce retailers, wholesalers, and various types of distributors, as well as directly to consumers under the OXO, Good Grips, Hydro Flask, Soft Works, OXO tot, OXO Brew, OXO Strive, OXO Outdoor, Osprey, PUR, Honeywell, Braun, Vicks, Drybar, Hot Tools, Revlon, and Bed Head brands. Helen of Troy Limited was incorporated in 1968 and is headquartered in El Paso, Texas.

Analyst Sentiment

63%
Buy

Based on 4 ratings

Analyst 1Y Forecast: $31.14

Average target (based on 3 sources)

Consensus Price Target

Low

$22

Median

$22

High

$22

Average

$22

Potential Upside: 16.6%

Price & Moving Averages

Loading chart...

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

πŸ“˜ HELEN OF TROY LTD (HELE) β€” Investment Overview

🧩 Business Model Overview

HELEN OF TROY commercializes consumer health, personal care, and home-use products through a brand-centric model. The company designs and sources products (often via a mix of owned sourcing and external manufacturing), then sells primarily through wholesale channels (major retail and specialty distributors) and an additional direct-to-consumer channel.

A key part of the value chain is category management and brand presence: HELE invests in product development, packaging/merchandising, and marketing support that translate into retailer shelf space and consumer repeat behavior. Once brands establish household recognition, the company benefits from ongoing replenishment purchasing by distributors and consumers who re-engage around new product drops, accessories, and seasonal demand patterns.

πŸ’° Revenue Streams & Monetisation Model

Revenue is driven by a blend of wholesale shipments and direct sales, supplemented by licensing and brand partnerships in certain categories where HELE monetizes brand equity without bearing the full manufacturing cost structure. Product revenue is largely transactional at the unit level; however, monetisation exhibits quasi-recurring characteristics because many categories generate replacement/upgrade cycles (e.g., accessories, consumables, repeat purchase formats) and because established brands earn sustained consumer shelf β€œpull.”

Margin drivers typically include:

  • Brand pricing power: premium positioning supports gross margin resilience relative to commodity competitors.
  • Mix management: higher-end models, accessories, and branded assortments tend to carry better economics than entry-level SKUs.
  • Operational leverage: manufacturing scale, better procurement terms, and freight/packaging efficiencies can improve contribution margins.
  • Working capital discipline: inventory turns and demand planning influence cash conversion, which often matters more than accounting earnings for consumer manufacturers.

🧠 Competitive Advantages & Market Positioning

HELE’s moat is primarily an intangible-asset and brand-driven advantage combined with practical switching costs created by established consumer preferences and retailer assortment commitments.

  • Intangible assets (brand equity): In consumer health and beauty, brand credibility lowers perceived risk for retailers and consumers, supporting better sell-through and reduced promotional intensity over time.
  • Customer stickiness / switching costs: Consumers often repurchase within the same brand ecosystem (accessories, replacement parts, compatible formats, and β€œknown performance”), making full-category switching less frequent.
  • Distribution relationships: Wholesale partners internalize HELE brands as an important part of their assortment. That creates friction for competitors attempting to displace HELE line-by-line, particularly when retailer merchandising and demand forecasting are involved.
  • Product development capability: Iterative improvements in design, materials, and usability can sustain relevance versus lower-cost entrants that rely on generic offerings.

While HELE does not rely on network effects in the classic sense, the combination of brand equity, consumer familiarity, and retailer assortment inertia makes market share difficult to gain and easier to defend.

πŸš€ Multi-Year Growth Drivers

Growth over a 5–10 year horizon is typically supported by category tailwinds and execution on portfolio strategy:

  • Premiumization: Consumers tend to trade up toward better-performing, more durable products in hydration, personal care, and beauty-related devices.
  • Wellness and personal-care routines: Expanded home-based routines support sustained demand for branded health and personal care products.
  • Accessory and ecosystem expansion: Building out companion products and replacement cycles can increase lifetime value beyond the initial unit purchase.
  • Omnichannel reach: Direct-to-consumer and e-commerce can improve visibility into customer demand, support higher-margin product mixes, and reduce reliance on any single retailer.
  • TAM expansion through product adjacency: Moving into adjacent segments where HELE can leverage brand trust and existing distribution pathways helps broaden the addressable customer base.

The most durable growth typically comes from maintaining brand relevance while systematically improving mix and cash conversionβ€”rather than relying on one-off promotional cycles.

⚠ Risk Factors to Monitor

  • Consumer demand cyclicality: Discretionary pull-backs can pressure wholesale replenishment and compress pricing.
  • Retail concentration and bargaining power: Loss of key accounts or unfavorable retailer terms can impair sell-through and margins.
  • Brand erosion and competitive intensity: Copycat products and aggressive private-label expansion can force higher promotions or reduce shelf impact.
  • Supply chain and input-cost volatility: Manufacturing lead times, logistics costs, and commodity/material inputs can affect gross margin and inventory risk.
  • Regulatory and labeling risk: Consumer health and personal care categories can face evolving rules around claims, safety, and labeling standards.
  • Execution risk in portfolio shifts: Acquisitions, licensing model changes, and new product launches can fail to reach expected demand, increasing working capital strain.

πŸ“Š Valuation & Market View

HELE is typically valued like a consumer brand company with manufacturing and distribution characteristics. Markets generally emphasize a combination of:

  • EV/EBITDA or EV/FCF for the durability of operating profitability and cash generation.
  • P/S (price-to-sales) when investors focus on growth, brand strength, and margin trajectory.

Valuation sensitivity usually increases when investors believe margins can expand via mix improvement and operational efficiency, and when working capital management supports cash flow. Conversely, valuation can compress when brand momentum weakens, promotional intensity rises, or inventory/returns distort cash conversion.

πŸ” Investment Takeaway

HELEN OF TROY offers a defensible long-term thesis centered on brand-driven intangible assets and consumer/retailer switching friction. The investment case is strongest when HELE sustains brand relevance, manages product mix toward higher-margin assortments, and protects cash conversion through disciplined inventory planningβ€”supporting durable free cash flow generation across consumer health and personal care cycles.


⚠ AI-generated β€” informational only. Validate using filings before investing.

Management sounds encouraged but essentially concedes the key story is still tariff/pricing leakage and margin drawdown. On the surface, Q3 was β€œin line” and net sales landed within the outlook range, with positives centered on Olive & June (nearly $38m sales; cash generation) and selective brand momentum (Osprey/OXO/Olive in June). However, the analyst pressure in Q&A surfaces that the earnings-power trough is not fixed by sales stability: the company is pivoting from cost cutting to revenue improvement, yet admits bottom-line pressure persists in Q4 because pricing realization is incomplete. Brian flags β€œleakage” versus pricing expectations (including stop-shipments to enforce uniform retail adoption), plus trade-down, mix deterioration, and higher promotion/trade expenses. The guidance cut (FY adjusted EPS $3.25–$3.75) and the larger-than-previous tariff drag on operating income (<$30m net vs prior ~ $20m) reinforce that the improvements are investment-led and will take timeβ€”likely more FY27 than immediate Q4.

AI IconGrowth Catalysts

  • Olive and June: nearly $38m sales in quarter; continues to outperform profitability expectations
  • Organic B2C revenue increased 21%
  • Product innovation/launches: Osprey + Hydro Flask cooler collaboration; Hydro Flask Eric Carle insulated kids’ bottle; OXO Trident cookware debut; Honeywell Allergen Plus HEPA air purifiers for cold/flu season
  • Commentary that ~30%–40% of the portfolio has innovation/opportunity to grow faster (targeted investment)

Business Development

  • Osprey, Olive and June, OXO, Braun, Pure, Vicks, and Honeywell referenced as priority brands/green-shoots
  • OXO added new tot and coffee SKUs at top partners (named partner not specified)

AI IconFinancial Highlights

  • Reported Q3 results in line with outlook; consolidated net sales -3.4% (favorable to outlook range); organic net sales -10.8%
  • Home & outdoor net sales -6.7%; Beauty & wellness net sales -0.5%
  • Consolidated gross margin -200 bps to 46.9% (higher tariffs + less favorable inventory obsolescence impact year-over-year; partly offset by Olive in June and lower commodity/product costs ex-tariffs)
  • SG&A ratio +160 bps (Olive and June acquisition, higher outbound freight, higher annual incentive comp, unfavorable operating leverage); adjusted operating margin -370 bps to 12.9% (650 bps home/outdoor, 120 bps beauty/wellness)
  • Adjusted EPS $1.71 (benefited from lower adjusted income tax expense partially offset by higher interest expense driven by higher average borrowings and tariff-related inventory carrying costs; and higher CapEx for China supplier transitions)
  • Leverage/net leverage ratio 3.77x vs 3.54x end of Q2 (increase due to lower trailing-12 EBITDA and tariff costs; plus unfavorable cash flow/balance sheet impacts of tariffs on outstanding debt)
  • Working capital/cash: Q3 free cash flow $29m despite $58m tariff drag; YTD free cash flow $29m including $58m incremental cash outflows for tariff payments and supplier transition costs

AI IconCapital Funding

  • Debt closed at $892m; $325m revolver availability; leverage covenant flexibility improved via amendment extending leverage ratio holiday and updating interest coverage definition
  • Credit agreement amendment provides greater flexibility to navigate evolving trade/external landscape

AI IconStrategy & Ops

  • Shift focus from cost cutting to revenue improvement/operating leverage: management explicitly pivoting away from β€œcut our way” strategy
  • Q4 and FY27 framed as beginning of a β€œwedge” of investment in brand building and innovation; bottom-line pressure expected short term as top line is lifted later
  • Operational hurdle in tariffs/pricing: still navigating markets with < full pricing realization due to stop shipments necessary to enforce retail adoption (beauty & wellness emphasized)
  • Supply chain: supplier diversification/dual sourcing; expected COGS from China tariffs reduced toward 25%–30% by 2026

AI IconMarket Outlook

  • FY2026 revenue tightened to $1.758b–$1.773b (Home & outdoor $812m–$819m vs prior $800m–$819m; Beauty & wellness $946m–$954m vs prior $939m–$961m)
  • FY2026 adjusted EPS lowered to $3.25–$3.75 (from prior higher range implied); driven by less than full pricing realization, consumer trade-down, less favorable mix, higher trade/promotion expense, and maintaining investments in people/brands
  • FY2026 GAAP SG&A ratio expected 38%–40%; adjusted effective tax rate 13.4%–14.7%
  • FY2026 year-end inventory expected $475m–$490m including $39m incremental tariff costs
  • Q4 commentary: sales expected not to be pulled down vs prior outlook; bottom-line divergence driven by unfavorable pricing realization, stop-shipment leakage, trade-down, less favorable mix, higher promotion expense, and margin compression

AI IconRisks & Headwinds

  • Tariff impact: YTD unmitigated tariffs $31.3m impact to gross profit; full-year unmitigated impact expected $50m–$55m gross profit drag
  • Full-year operating income tariff impact now expected < $30m net of mitigation actions vs prior ~ $20m (increase attributed primarily to delayed timing of pricing realization)
  • Pricing realization hurdle: most price adjustments implemented, but residual stop-shipments create ongoing leakage; residual impact expected to carry into Q4
  • Organic growth weakness: organic net sales -10.8% driven by tariff-related revenue disruption (pause/cancellation of direct import orders from China; changing China market dynamics; stop shipments)
  • Market behavior risk: retailer inventory management remains tight; consumer trade-down and more promotional environment expected to persist through Q4
  • Category/seasonal pressure: wellness impacted by below-average illness season; beauty impacted by soft consumer demand, competitive pressures, and cancellation of direct import orders
  • Leverage risk: higher leverage ratio (3.77x) from lower trailing EBITDA due to tariff costs; tariff effects on cash flow/balance sheet

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the HELE Q3 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Fundamentals Overview

Loading fundamentals overview...

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-11-30

"HELE reported a revenue of $512.83M but incurred a net loss of $84.06M, resulting in an EPS of -$3.65. The company generated positive operating cash flow of $11.94M, although its free cash flow mirrors this figure due to zero capital expenditures. The balance sheet shows total assets of $2.34B, with total liabilities amounting to $1.49B and equity at $852.26M. While the company has substantial revenues, its profitability is severely impacted by negative net income, and high net debt of $919.75M poses a challenge. Market performance is concerning with a 1-year price decline of approximately 72%. The stock price currently stands at $14.86, significantly lower than the consensus price target of $22. Despite the struggles related to profitability and shareholder returns, the company does show positive cash flow characteristics, which may be favorable for future growth."

Revenue Growth

Neutral

The revenue of $512.83M represents a substantial figure, indicating some growth.

Profitability

Neutral

The company reported a significant net loss, affecting overall profitability.

Cash Flow Quality

Fair

Positive operating and free cash flow indicate potential for liquidity management.

Leverage & Balance Sheet

Caution

The high net debt relative to equity suggests leverage concerns.

Shareholder Returns

Neutral

A significant drop in stock price with no dividends reflects poor shareholder returns.

Analyst Sentiment & Valuation

Neutral

While the stock price is below target, analyst sentiment remains cautious due to losses.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
πŸ“

SEC Filings (HELE)

Β© 2026 Stock Market Info β€” Helen of Troy Limited (HELE) Financial Profile